media

-Yvar Verhoeven meets students after his presentation at John’s Hopkins, November 13th, 2009. -The first patient to be treated with Dr. Ko’s 3BP compound. -A Translational Study “Case Report” on the Small Molecule “Energy Blocker” 3-Bromopyruvate (3BP) as a Potent

NCI and NIH Mitochondria Interest Group Seminar: Johns Hopkins’ Pedersen Addresses Role of Mitochondria in Cancer https://videocast.nih.gov/summary.asp?live=7542&bhcp=1